Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 893 entries
Sorted by: Best Match Show Resources per page
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.

United European gastroenterology journal

Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF.
PMID: 26535124
United European Gastroenterol J. 2015 Oct;3(5):453-61. doi: 10.1177/2050640615583587.

BACKGROUND: Endoglin is an endothelial cell membrane receptor essential for angiogenesis and highly expressed on the vasculature of many tumor types, including hepatocellular carcinoma (HCC). TRC105 is a chimeric IgG1 anti-CD105 monoclonal antibody that inhibits angiogenesis and tumor growth...

Cite
Duffy AG, Ulahannan SV, Cao L, et al. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol J. 2015;3(5):453-61doi: 10.1177/2050640615583587.
Duffy, A. G., Ulahannan, S. V., Cao, L., Rahma, O. E., Makarova-Rusher, O. V., Kleiner, D. E., Fioravanti, S., Walker, M., Carey, S., Yu, Y., Venkatesan, A. M., Turkbey, B., Choyke, P., Trepel, J., Bollen, K. C., Steinberg, S. M., Figg, W. D., & Greten, T. F. (2015). A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European gastroenterology journal, 3(5), 453-61. https://doi.org/10.1177/2050640615583587
Duffy, A G, et al. "A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib." United European gastroenterology journal vol. 3,5 (2015): 453-61. doi: https://doi.org/10.1177/2050640615583587
Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol J. 2015 Oct;3(5):453-61. doi: 10.1177/2050640615583587. PMID: 26535124; PMCID: PMC4625750.
Copy Download .nbib Format: NLM
Molecular imaging in endoscopy.

United European gastroenterology journal

Hoetker MS, Goetz M.
PMID: 24917945
United European Gastroenterol J. 2013 Apr;1(2):84-92. doi: 10.1177/2050640613483291.

Molecular imaging focuses on the molecular signature of cells rather than morphological changes in the tissue. The need for this novel type of imaging arises from the often difficult detection and characterization especially of small and/or premalignant lesions. Molecular...

Cite
Hoetker MS, Goetz M. Molecular imaging in endoscopy. United European Gastroenterol J. 2013;1(2):84-92doi: 10.1177/2050640613483291.
Hoetker, M. S., & Goetz, M. (2013). Molecular imaging in endoscopy. United European gastroenterology journal, 1(2), 84-92. https://doi.org/10.1177/2050640613483291
Hoetker, Michael S, and Goetz, Martin. "Molecular imaging in endoscopy." United European gastroenterology journal vol. 1,2 (2013): 84-92. doi: https://doi.org/10.1177/2050640613483291
Hoetker MS, Goetz M. Molecular imaging in endoscopy. United European Gastroenterol J. 2013 Apr;1(2):84-92. doi: 10.1177/2050640613483291. PMID: 24917945; PMCID: PMC4040736.
Copy Download .nbib Format: NLM
Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study.

United European gastroenterology journal

Chaput U, Heresbach D, Audureau E, Vanbiervliet G, Gaudric M, Bichard P, Bauret P, Coumaros D, Ponchon T, Fumex F, Bensoussan E, Lamouliatte H, Chryssostalis A, Robin F, Prat F.
PMID: 24917946
United European Gastroenterol J. 2013 Apr;1(2):93-102. doi: 10.1177/2050640613476501.

BACKGROUND: Some esophageal strictures resist endoscopic treatments. There is a need for new treatments, such as specifically designed stents.OBJECTIVE: Our study sought to compare the results achieved with a standard, fully covered metallic stent (FCMS) and those achieved using...

Cite
Chaput U, Heresbach D, Audureau E, et al. Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study. United European Gastroenterol J. 2013;1(2):93-102doi: 10.1177/2050640613476501.
Chaput, U., Heresbach, D., Audureau, E., Vanbiervliet, G., Gaudric, M., Bichard, P., Bauret, P., Coumaros, D., Ponchon, T., Fumex, F., Bensoussan, E., Lamouliatte, H., Chryssostalis, A., Robin, F., & Prat, F. (2013). Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study. United European gastroenterology journal, 1(2), 93-102. https://doi.org/10.1177/2050640613476501
Chaput, Ulriikka, et al. "Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study." United European gastroenterology journal vol. 1,2 (2013): 93-102. doi: https://doi.org/10.1177/2050640613476501
Chaput U, Heresbach D, Audureau E, Vanbiervliet G, Gaudric M, Bichard P, Bauret P, Coumaros D, Ponchon T, Fumex F, Bensoussan E, Lamouliatte H, Chryssostalis A, Robin F, Prat F. Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study. United European Gastroenterol J. 2013 Apr;1(2):93-102. doi: 10.1177/2050640613476501. PMID: 24917946; PMCID: PMC4040734.
Copy Download .nbib Format: NLM
Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan.

United European gastroenterology journal

Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T.
PMID: 24917957
United European Gastroenterol J. 2013 Jun;1(3):175-83. doi: 10.1177/2050640613485238.

BACKGROUND: The GerdQ scoring system may be a useful tool for managing gastro-oesophageal reflux disease. However, GerdQ has not been fully validated in Asian countries.OBJECTIVE: To validate the Japanese version of GerdQ and to compare this version to the...

Cite
Suzuki H, Matsuzaki J, Okada S, et al. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J. 2013;1(3):175-83doi: 10.1177/2050640613485238.
Suzuki, H., Matsuzaki, J., Okada, S., Hirata, K., Fukuhara, S., & Hibi, T. (2013). Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European gastroenterology journal, 1(3), 175-83. https://doi.org/10.1177/2050640613485238
Suzuki, Hidekazu, et al. "Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan." United European gastroenterology journal vol. 1,3 (2013): 175-83. doi: https://doi.org/10.1177/2050640613485238
Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J. 2013 Jun;1(3):175-83. doi: 10.1177/2050640613485238. PMID: 24917957; PMCID: PMC4040759.
Copy Download .nbib Format: NLM
UEG Week: Late-breaking abstract submission.

United European gastroenterology journal

[No authors listed]
PMID: 24917963
United European Gastroenterol J. 2013 Jun;1(3):216. doi: 10.1177/2050640613492682.

No abstract available.

Cite
UEG Week: Late-breaking abstract submission. United European Gastroenterol J. 2013;1(3):216doi: 10.1177/2050640613492682.
(2013). UEG Week: Late-breaking abstract submission. United European gastroenterology journal, 1(3), 216. https://doi.org/10.1177/2050640613492682
"UEG Week: Late-breaking abstract submission." United European gastroenterology journal vol. 1,3 (2013): 216. doi: https://doi.org/10.1177/2050640613492682
UEG Week: Late-breaking abstract submission. United European Gastroenterol J. 2013 Jun;1(3):216. doi: 10.1177/2050640613492682. PMID: 24917963; PMCID: PMC4040752.
Copy Download .nbib Format: NLM
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis.

United European gastroenterology journal

Ikeura T, Manfredi R, Zamboni G, Negrelli R, Capelli P, Amodio A, Caliò A, Colletta G, Gabbrielli A, Benini L, Okazaki K, Vantini I, Frulloni L.
PMID: 24917972
United European Gastroenterol J. 2013 Aug;1(4):276-84. doi: 10.1177/2050640613495196.

BACKGROUND: International consensus diagnostic criteria (ICDC) have been proposed to classify autoimmune pancreatitis (AIP) in type 1, type 2, or not otherwise specified.OBJECTIVE: Aim was to apply the ICDC to an Italian series of patients to evaluate the incidence...

Cite
Ikeura T, Manfredi R, Zamboni G, et al. Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterol J. 2013;1(4):276-84doi: 10.1177/2050640613495196.
Ikeura, T., Manfredi, R., Zamboni, G., Negrelli, R., Capelli, P., Amodio, A., Caliò, A., Colletta, G., Gabbrielli, A., Benini, L., Okazaki, K., Vantini, I., & Frulloni, L. (2013). Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European gastroenterology journal, 1(4), 276-84. https://doi.org/10.1177/2050640613495196
Ikeura, Tsukasa, et al. "Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis." United European gastroenterology journal vol. 1,4 (2013): 276-84. doi: https://doi.org/10.1177/2050640613495196
Ikeura T, Manfredi R, Zamboni G, Negrelli R, Capelli P, Amodio A, Caliò A, Colletta G, Gabbrielli A, Benini L, Okazaki K, Vantini I, Frulloni L. Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterol J. 2013 Aug;1(4):276-84. doi: 10.1177/2050640613495196. PMID: 24917972; PMCID: PMC4040792.
Copy Download .nbib Format: NLM
Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.

United European gastroenterology journal

Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF.
PMID: 24917983
United European Gastroenterol J. 2013 Oct;1(5):351-7. doi: 10.1177/2050640613501507.

OBJECTIVE: Epidemiological and clinical information on fibrolamellar hepatocellular carcinoma (fHCC) is scarce. We performed a Surveillance, Epidemiology and End Results (SEER) database analysis with the aim of collecting information to better understand the biology and clinical aspects of this...

Cite
Eggert T, McGlynn KA, Duffy A, et al. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013;1(5):351-7doi: 10.1177/2050640613501507.
Eggert, T., McGlynn, K. A., Duffy, A., Manns, M. P., Greten, T. F., & Altekruse, S. F. (2013). Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European gastroenterology journal, 1(5), 351-7. https://doi.org/10.1177/2050640613501507
Eggert, Tobias, et al. "Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database." United European gastroenterology journal vol. 1,5 (2013): 351-7. doi: https://doi.org/10.1177/2050640613501507
Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013 Oct;1(5):351-7. doi: 10.1177/2050640613501507. PMID: 24917983; PMCID: PMC4040774.
Copy Download .nbib Format: NLM
Gastrointestinal motility revisited: The wireless motility capsule.

United European gastroenterology journal

Farmer AD, Scott SM, Hobson AR.
PMID: 24917991
United European Gastroenterol J. 2013 Dec;1(6):413-21. doi: 10.1177/2050640613510161.

INTRODUCTION: The wireless motility capsule (WMC) is a novel ambulatory technology that concurrently measures intraluminal pH, temperature, and pressure as it traverses the gastrointestinal tract.OBJECTIVES: We aim to provide a concise summary of the WMC, detailing the procedure for...

Cite
Farmer AD, Scott SM, Hobson AR. Gastrointestinal motility revisited: The wireless motility capsule. United European Gastroenterol J. 2013;1(6):413-21doi: 10.1177/2050640613510161.
Farmer, A. D., Scott, S. M., & Hobson, A. R. (2013). Gastrointestinal motility revisited: The wireless motility capsule. United European gastroenterology journal, 1(6), 413-21. https://doi.org/10.1177/2050640613510161
Farmer, Adam D, et al. "Gastrointestinal motility revisited: The wireless motility capsule." United European gastroenterology journal vol. 1,6 (2013): 413-21. doi: https://doi.org/10.1177/2050640613510161
Farmer AD, Scott SM, Hobson AR. Gastrointestinal motility revisited: The wireless motility capsule. United European Gastroenterol J. 2013 Dec;1(6):413-21. doi: 10.1177/2050640613510161. PMID: 24917991; PMCID: PMC4040748.
Copy Download .nbib Format: NLM
Laparoscopic versus open appendectomy in adults and children: A meta-analysis of randomized controlled trials.

United European gastroenterology journal

Dai L, Shuai J.
PMID: 28588886
United European Gastroenterol J. 2017 Jun;5(4):542-553. doi: 10.1177/2050640616661931. Epub 2016 Aug 16.

OBJECTIVE: The aim of this study was to evaluate the differences of laparoscopic appendectomy (LA) versus open appendectomy (OA) in adults and children.METHODS: Randomized controlled trials (RCTs) comparing LA and OA in adults and children between January 1992-March 2016...

Cite
Dai L, Shuai J. Laparoscopic versus open appendectomy in adults and children: A meta-analysis of randomized controlled trials. United European Gastroenterol J. 2016;5(4):542-553doi: 10.1177/2050640616661931.
Dai, L., & Shuai, J. (2017). Laparoscopic versus open appendectomy in adults and children: A meta-analysis of randomized controlled trials. United European gastroenterology journal, 5(4), 542-553. https://doi.org/10.1177/2050640616661931
Dai, Liping, and Shuai, Jian. "Laparoscopic versus open appendectomy in adults and children: A meta-analysis of randomized controlled trials." United European gastroenterology journal vol. 5,4 (2017): 542-553. doi: https://doi.org/10.1177/2050640616661931
Dai L, Shuai J. Laparoscopic versus open appendectomy in adults and children: A meta-analysis of randomized controlled trials. United European Gastroenterol J. 2017 Jun;5(4):542-553. doi: 10.1177/2050640616661931. Epub 2016 Aug 16. PMID: 28588886; PMCID: PMC5446136.
Copy Download .nbib Format: NLM
The safety of same-day CT colonography following incomplete colonoscopy with polypectomy.

United European gastroenterology journal

Lara LF, Avalos D, Huynh H, Jimenez-Cantisano B, Padron M, Pimentel R, Erim T, Schneider A, Ukleja A, Parlade A, Castro F.
PMID: 26279844
United European Gastroenterol J. 2015 Aug;3(4):358-63. doi: 10.1177/2050640615577881.

BACKGROUND: Concerns about the risk of bowel perforation for same-day computed tomography colonography (CTC) following an incomplete colonoscopy with polypectomy may lead to unnecessarily postponing the CTC.OBJECTIVE: The objective of this article is to describe the complications including colon...

Cite
Lara LF, Avalos D, Huynh H, et al. The safety of same-day CT colonography following incomplete colonoscopy with polypectomy. United European Gastroenterol J. 2015;3(4):358-63doi: 10.1177/2050640615577881.
Lara, L. F., Avalos, D., Huynh, H., Jimenez-Cantisano, B., Padron, M., Pimentel, R., Erim, T., Schneider, A., Ukleja, A., Parlade, A., & Castro, F. (2015). The safety of same-day CT colonography following incomplete colonoscopy with polypectomy. United European gastroenterology journal, 3(4), 358-63. https://doi.org/10.1177/2050640615577881
Lara, Luis F, et al. "The safety of same-day CT colonography following incomplete colonoscopy with polypectomy." United European gastroenterology journal vol. 3,4 (2015): 358-63. doi: https://doi.org/10.1177/2050640615577881
Lara LF, Avalos D, Huynh H, Jimenez-Cantisano B, Padron M, Pimentel R, Erim T, Schneider A, Ukleja A, Parlade A, Castro F. The safety of same-day CT colonography following incomplete colonoscopy with polypectomy. United European Gastroenterol J. 2015 Aug;3(4):358-63. doi: 10.1177/2050640615577881. PMID: 26279844; PMCID: PMC4528210.
Copy Download .nbib Format: NLM
Non-coeliac gluten sensitivity: piecing the puzzle together.

United European gastroenterology journal

Biesiekierski JR, Iven J.
PMID: 25922675
United European Gastroenterol J. 2015 Apr;3(2):160-5. doi: 10.1177/2050640615578388.

The avoidance of wheat- and gluten-containing products is a worldwide phenomenon. While coeliac disease is well-established, much remains unknown about whether gluten can be a trigger of gastrointestinal and/or extra-intestinal symptoms in patients without coeliac disease. In this article,...

Cite
Biesiekierski JR, Iven J. Non-coeliac gluten sensitivity: piecing the puzzle together. United European Gastroenterol J. 2015;3(2):160-5doi: 10.1177/2050640615578388.
Biesiekierski, J. R., & Iven, J. (2015). Non-coeliac gluten sensitivity: piecing the puzzle together. United European gastroenterology journal, 3(2), 160-5. https://doi.org/10.1177/2050640615578388
Biesiekierski, Jessica R, and Iven, Julie. "Non-coeliac gluten sensitivity: piecing the puzzle together." United European gastroenterology journal vol. 3,2 (2015): 160-5. doi: https://doi.org/10.1177/2050640615578388
Biesiekierski JR, Iven J. Non-coeliac gluten sensitivity: piecing the puzzle together. United European Gastroenterol J. 2015 Apr;3(2):160-5. doi: 10.1177/2050640615578388. PMID: 25922675; PMCID: PMC4406911.
Copy Download .nbib Format: NLM
Dental erosions and other extra-oesophageal symptoms of gastro-oesophageal reflux disease: Evidence, treatment response and areas of uncertainty.

United European gastroenterology journal

Pauwels A.
PMID: 25922676
United European Gastroenterol J. 2015 Apr;3(2):166-70. doi: 10.1177/2050640615575972.

Extra-oesophageal symptoms of gastro-oesophageal reflux disease (GORD) are often studied, but remain a subject of debate. It has been clearly shown that there is a relationship between the extra-oesophageal symptoms chronic cough, asthma, laryngitis and dental erosion and GORD....

Cite
Pauwels A. Dental erosions and other extra-oesophageal symptoms of gastro-oesophageal reflux disease: Evidence, treatment response and areas of uncertainty. United European Gastroenterol J. 2015;3(2):166-70doi: 10.1177/2050640615575972.
Pauwels, A. (2015). Dental erosions and other extra-oesophageal symptoms of gastro-oesophageal reflux disease: Evidence, treatment response and areas of uncertainty. United European gastroenterology journal, 3(2), 166-70. https://doi.org/10.1177/2050640615575972
Pauwels, Ans. "Dental erosions and other extra-oesophageal symptoms of gastro-oesophageal reflux disease: Evidence, treatment response and areas of uncertainty." United European gastroenterology journal vol. 3,2 (2015): 166-70. doi: https://doi.org/10.1177/2050640615575972
Pauwels A. Dental erosions and other extra-oesophageal symptoms of gastro-oesophageal reflux disease: Evidence, treatment response and areas of uncertainty. United European Gastroenterol J. 2015 Apr;3(2):166-70. doi: 10.1177/2050640615575972. PMID: 25922676; PMCID: PMC4406905.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 893 entries